Largest-ever study re-evaluates this important question with today’s technology

March 31, 2008 - Percutaneous coronary intervention (PCI)—which uses a combination of catheter-mounted balloons and stents to open a completely blocked coronary artery and restore blood flow to the heart—is the best treatment for heart attack when performed rapidly. However, few hospitals can meet the 90-minute treatment goal unless they have a cardiac catheterization laboratory on site.

March 31, 2008 - Over the years, interventional cardiologists have made many improvements in percutaneous coronary intervention (PCI) for patients with heart attack, among the most important, refinements in the selection and administration of drugs that prevent unwanted blood clotting.

March 31, 2008 - Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study.

March 31, 2008 - A device that catches bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) has failed to show that it can reduce rates of major cardiovascular complications in patients with acute coronary syndromes, a condition that encompasses unstable angina and a type of heart attack known as non-ST-elevation myocardial infarction (NSTEMI).

Showcased at ACC, the Philips 12-Lead ECG Transfer Station receives the current ECGs from the HeartStart MRx and makes it available to ED staff, as well as to offsite cardiologists via secure email, PDA or fax.

The upgraded Philips HeartStart MRx monitor/defibrillator aims to further help the industry realize door-to-balloon guidelines of less than 90 minutes by enabling hospitals to start the clock sooner, organizing their resources, including activating the cath lab, before a STEMI patient arrives.

Philips brought to ACC its Xper Information Management, a personalized cardiovascular workflow solution that presents a variety of new features for reporting, image review, scheduling, inventory and intelligent data management.

Toshiba America Medical Systems presented the FDA 510(k) cleared Artida ultrasound system, designed to meet the demands of the growing cardiac 4D market, today at the American College of Cardiology's 57th Annual Scientific Session in Chicago, IL.

With Artida's real-time multi-planar reformatting capabilities, physicians should be able to quantify global and regional LV function, including LV ejection fraction, volume and severity of regurgitation. Arbitrary views of the heart not available in 2D imaging are also obtained that can help with surgical planning.

March 30, 2008 - One-year data from the ENDEAVOR IV trial showing strong clinical efficacy for Medtronic's Endeavor drug-eluting stent were presented today at the American College of Cardiology meeting held in Chicago, IL.

March 30, 2008 - Using the Export Aspiration Catheter from Medtronic, before stenting, in patients suffering acute myocardial infarction (AMI) can significantly improve blood flow and survival rates compared to conventional treatment with percutaneous coronary intervention (PCI) alone, according to results of a Dutch study presented today at the American College of Cardiology meeting.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now